Cardiovascular risk factors in middle-aged women and the association with use of hormone therapy: results from a population-based study of Swedish women. The Women's Health in the Lund Area (WHILA) Study

References

• Barrett-Connor E. The menopause, hormone replacement and cardiovascular disease: the epidemiologic evidence. Maturitas 1996;23: 227–34
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willet WC, et al. Postmenopausal estrogen therapy and cardiovas-cular disease. N Engl J Med 1991;325:756–62
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530–7
   PubMed Web of Science ®Google Scholar
• Rödström K, Bengtsson C, Lissner L, et al. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospec-tive cohort study in Gothenburg, Sweden. Br Med J 1999;319:890–3
   Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605–13
   Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/ progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002;288: 49–57
   Google Scholar
• Cherry N, Gilmour K, Hannaford P, et al. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised place-bo controlled trial. Lancet 2002;360:2001–8
   PubMed Web of Science ®Google Scholar
• Clarke SC, Kelleher J, Lloyd-Jones H, et al. A study of hormone replacement therapy in post-menopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study. Br J Obstet Gynaecol 2002;109:1056–62
   Google Scholar
• Viscoli CM, Brass LM, Kernan WN. A clinical trial of estrogen-replacement therapy after is-chemic stroke. N Engl J Med 2001;345:1243–9
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61–109
   Google Scholar
• The Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopau-sal women. J Am Med Assoc 2002;288:321–33
   Google Scholar
• The Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–34
   Google Scholar
• Matthews KA, Kuller LH, Sutton-Tyrrell K, et al. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001;32:1104–11
   Google Scholar
• Li C,Wilawan K, Samsioe G, et al. Health profile of middle-aged women: a population based study of Swedish women. The Women's Health in the Lund Area (WHILA) study. Hum Reprod 2002;17:1379–85
   Google Scholar
• Li C, Samsioe G, Wilaman K, et al. Effects of norethisterone acetate addition to estradiol in long term HRT. A population based study of Swedish women. The Women's Health in Lund Area (WHILA) study. Maturitas 2000;36:139–52
   Google Scholar
• Nerbrand C, Lidfeldt J, Nyberg P, et al. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. Maturitas 2004;48:161–9
   PubMed Web of Science ®Google Scholar
• Lidfeldt J, Nerbrand C, Samsioe G, et al. Ascreening procedure detecting high-yield can-didates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur J Epidemiol 2001;17:943–51
   Google Scholar
• Gallo LC, Matthews KA, Kuller LH, et al. Educational attainment and coronary and aortic calcification in postmenopausal women. Psycho-som Med 2001;63:925–35
   PubMed Web of Science ®Google Scholar
• Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971–8
   PubMed Web of Science ®Google Scholar
• Merlo J, Lynch JW, Yang M, et al. Effect of neighborhood social participation on individual use of hormone replacement therapy and anti-hypertensive medication: a multilevel analysis. Am J Epidemiol 2003;157:774–83
   PubMed Web of Science ®Google Scholar
• Sowers JR. Diabetes mellitus and cardiovascular disease in women (review). Arch Intern Med 1998;158:617–21
   PubMed Web of Science ®Google Scholar
• Kaseta JR, Skafar DF, Ram JL, et al. Cardio-vascular disease in the diabetic woman (review). J Clin Endocrinol Metab 1999;84:1835–8
   PubMed Web of Science ®Google Scholar
• Walsh BW, Shiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipo-proteins. N Engl J Med 1991;325:1196–204
   PubMed Web of Science ®Google Scholar
• Lobo RA. Effects of hormonal replacement on lipids and lipoprteins in postmenopausal wo-men. J Clin Endocrinol Metab 1991;73:925–30
   PubMed Web of Science ®Google Scholar
• Samaras K, Hayward CS, Sullivan D, et al. Effects of postmenopausal HRT on central abdominal fat, glycemic control, lipid metabo-lism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care 1999;22 : 1401–7
   PubMed Web of Science ®Google Scholar
• Christiansen C, Riis BJ. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipo-proteins, and bleeding pattern. Br J Obstet Gynaecol 1990;97:1087–92
   PubMedGoogle Scholar
• Amigoni S, Morelli P, Parazzini F, et al. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 2000;34:25–32
   PubMed Web of Science ®Google Scholar
• Scuteri A, Bos AJ, Brant LJ, et al. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 2001;135:229–35
   PubMed Web of Science ®Google Scholar
• Vestergaard P. Hermann AP, Stilgren L, et al. Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure- a randomised controlled study. Ma-turitas 2003;46:123–32
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEP Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. The PostmenopausalEstrogen/ProgestinInter-ventions (PEP!) Trial. J Am Med Assoc 1995;273:199–208
   Google Scholar